Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,921Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Malladi Drugs & Pharmaceuticals Limited

02 1Acharya Chemicals

03 1Corey Organics

04 1Darshan Pharma Chem

05 5Nanjing Lift Pharmaceutical Technology Co., Ltd

06 2Nantong Chem-land

07 3Ningbo Chemgoo Pharma Tech

08 1SLN Pharmachem

09 1Sanpra Synthesis

10 7Shandong Boyuan Pharmaceutical

11 1Shree Ganesh Remedies

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Peptide Therapy Summit
Not Confirmed
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMalladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.

CAS Number : 202197-26-0

End Use API : Lapatinib Ditosylate

About The Company : Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufa...

Malladi

02

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 1885-29-6

End Use API : Lapatinib Ditosylate

About The Company : Established in 1975, Acharya Group is a trusted and well-established chemical manufacturing company renowned for its commitment to technological excellence. Ach...

blank

03

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 1885-29-6

End Use API : Lapatinib Ditosylate

About The Company : Corey Organics is focused in developing and manufacturing of Active Pharmaceutical Ingredients (APIs), registered Pharma Intermediates, Fine Chemicals and Pyrid...

blank

04

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 4637-24-5

End Use API : Lapatinib Ditosylate

About The Company : Darshan Pharmachem, founded in 2011 in Ankleshwar, is a leading pharmaceutical company specializing in high-quality and innovative API intermediates. We are com...

blank

05

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 27329-70-0

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

06

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 231278-20-9

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

07

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 104458-24-4

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

08

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 231278-84-5

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

09

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 202197-26-0

End Use API : Lapatinib Ditosylate

About The Company : Nanjing Lift Pharmaceutical is a specialized company concentrating on the R&D, production, marketing and technical service of APIs, pharmaceutical intermediates...

blank

10

Peptide Therapy Summit
Not Confirmed
arrow
Peptide Therapy Summit
Not Confirmed
arrow

CAS Number : 231278-20-9

End Use API : Lapatinib Ditosylate

About The Company : Nantong Chem-land Co., Ltd. is located in Nantong city, a developed port city which distance from Shanghai is only 1.5 hours by car. Established in 2006, we hav...

blank